Vanda Pharmaceuticals
VNDA
#8786
Rank
A$0.33 B
Marketcap
A$5.54
Share price
6.41%
Change (1 day)
-18.52%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): A$0.40

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$6.72. In 2022 the company made an earnings per share (EPS) of A$0.17 a decrease over its 2021 EPS that were of A$0.87.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$0.40132.19%
2022A$0.17-80%
2021A$0.8739.53%
2020A$0.62-80.18%
2019A$3.15334%
2018A$0.73-247.06%
2017A-$0.49-19.05%
2016A-$0.61-55.32%
2015A-$1.36-347.37%
2014A$0.55-156.72%
2013A-$0.97-31.63%
2012A-$1.42172.22%
2011A-$0.52-238.46%
2010A$0.38-119.7%
2009A-$1.92-31.61%
2008A-$2.80-31.32%
2007A-$4.08-99.27%
2006A-$562.2136045.14%
2005A-$1.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.70-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.62-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.10-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.78-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.44-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.56-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
A-$6.37-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA